141 related articles for article (PubMed ID: 22362817)
1. Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis.
Momi S; Monopoli A; Alberti PF; Falcinelli E; Corazzi T; Conti V; Miglietta D; Ongini E; Minuz P; Gresele P
Cardiovasc Res; 2012 Jun; 94(3):428-38. PubMed ID: 22362817
[TBL] [Abstract][Full Text] [Related]
2. NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties.
Momi S; Impagnatiello F; Guzzetta M; Caracchini R; Guglielmini G; Olivieri R; Monopoli A; Gresele P
Eur J Pharmacol; 2007 Sep; 570(1-3):115-24. PubMed ID: 17632098
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.
Nachtigal P; Pospisilova N; Jamborova G; Pospechova K; Solichova D; Andrys C; Zdansky P; Micuda S; Semecky V
Life Sci; 2008 Mar; 82(13-14):708-17. PubMed ID: 18289605
[TBL] [Abstract][Full Text] [Related]
4. Suppression of inflammatory response and endothelial nitric oxide synthase downregulation in hyperlipidaemic C57BL/6J mice by eugenosedin-A.
Shen KP; Lin HL; Chang WT; An LM; Chen IJ; Wu BN
J Pharm Pharmacol; 2011 Jun; 63(6):860-8. PubMed ID: 21585385
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory and anti-thrombotic intervention strategies using atorvastatin, clopidogrel and knock-down of CD40L do not modify radiation-induced atherosclerosis in ApoE null mice.
Hoving S; Heeneman S; Gijbels MJ; te Poele JA; Pol JF; Gabriels K; Russell NS; Daemen MJ; Stewart FA
Radiother Oncol; 2011 Oct; 101(1):100-8. PubMed ID: 22001104
[TBL] [Abstract][Full Text] [Related]
6. MDOC and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE-/- mouse model of atherosclerosis.
Nachtigal P; Pospisilova N; Pospechova K; Jamborova G; Kopecky M; Jaynes R; Briestensky J; Santar I; Smahelova A; Solichova D; Zdansky P; Semecky V
Life Sci; 2006 Mar; 78(17):1983-9. PubMed ID: 16305803
[TBL] [Abstract][Full Text] [Related]
7. The nitric oxide-donating pravastatin derivative, NCX 6550 [(1S-[1alpha(betaS*, deltaS*), 2alpha, 6alpha, 8beta-(R*), 8a alpha]]-1,2,6,7,8,8a-Hexahydro-beta, delta, 6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1-naphtalene-heptanoic acid 4-(nitrooxy)butyl ester)], reduces splenocyte adhesion and reactive oxygen species generation in normal and atherosclerotic mice.
Dever G; Spickett CM; Kennedy S; Rush C; Tennant G; Monopoli A; Wainwright CL
J Pharmacol Exp Ther; 2007 Jan; 320(1):419-26. PubMed ID: 17005918
[TBL] [Abstract][Full Text] [Related]
8. Torcetrapib does not reduce atherosclerosis beyond atorvastatin and induces more proinflammatory lesions than atorvastatin.
de Haan W; de Vries-van der Weij J; van der Hoorn JW; Gautier T; van der Hoogt CC; Westerterp M; Romijn JA; Jukema JW; Havekes LM; Princen HM; Rensen PC
Circulation; 2008 May; 117(19):2515-22. PubMed ID: 18458167
[TBL] [Abstract][Full Text] [Related]
9. The roles of nitric oxide and hydrogen sulfide in the anti-atherosclerotic effect of atorvastatin.
Liu X; Ma D; Zheng S; Zha K; Feng J; Cai Y; Jiang F; Li J; Fan Z
J Cardiovasc Med (Hagerstown); 2015 Jan; 16(1):22-8. PubMed ID: 24933195
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin has distinct effects on endothelial markers in different mouse models of atherosclerosis.
Nachtigal P; Jamborova G; Pospisilova N; Pospechova K; Solichova D; Zdansky P; Semecky V
J Pharm Pharm Sci; 2006; 9(2):222-30. PubMed ID: 16959191
[TBL] [Abstract][Full Text] [Related]
11. Biphasic effects of atorvastatin on inflammation.
Garjani A; Andalib S; Ziaee M; Maleki-Dizaji N
Pak J Pharm Sci; 2008 Apr; 21(2):125-30. PubMed ID: 18390442
[TBL] [Abstract][Full Text] [Related]
12. Low-dose treatment with atorvastatin leads to anti-oxidative and anti-inflammatory effects in diabetes mellitus.
Riad A; Du J; Stiehl S; Westermann D; Mohr Z; Sobirey M; Doehner W; Adams V; Pauschinger M; Schultheiss HP; Tschöpe C
Eur J Pharmacol; 2007 Aug; 569(3):204-11. PubMed ID: 17669395
[TBL] [Abstract][Full Text] [Related]
13. Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice.
Verschuren L; Kleemann R; Offerman EH; Szalai AJ; Emeis SJ; Princen HM; Kooistra T
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):161-7. PubMed ID: 15514207
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice.
Berbée JF; Wong MC; Wang Y; van der Hoorn JW; Khedoe PP; van Klinken JB; Mol IM; Hiemstra PS; Tsikas D; Romijn JA; Havekes LM; Princen HM; Rensen PC
J Nutr Biochem; 2013 Aug; 24(8):1423-30. PubMed ID: 23337345
[TBL] [Abstract][Full Text] [Related]
15. Up-regulating PPAR-γ expression and NO concentration, and down-regulating PAI-1 concentration in a rabbit atherosclerotic model: the possible antiatherogenic and antithrombotic effects of atorvastatin.
Yang P; Li Y; Li JJ; Qin L; Li XY
Int J Cardiol; 2010 Mar; 139(3):213-7. PubMed ID: 19307033
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin Increases Endoglin, SMAD2, Phosphorylated SMAD2/3 and eNOS Expression in ApoE/LDLR Double Knockout Mice.
Nachtigal P; Pospisilova N; Vecerova L; Micuda S; Brcakova E; Pospechova K; Semecky V
J Atheroscler Thromb; 2009 Jun; 16(3):265-74. PubMed ID: 19556713
[TBL] [Abstract][Full Text] [Related]
17. Statins exert differential effects on angiotensin II-induced atherosclerosis, but no benefit for abdominal aortic aneurysms.
Wang JA; Chen WA; Wang Y; Zhang S; Bi H; Hong B; Luo Y; Daugherty A; Xie X
Atherosclerosis; 2011 Jul; 217(1):90-6. PubMed ID: 21481872
[TBL] [Abstract][Full Text] [Related]
18. RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice.
Sun L; Ishida T; Yasuda T; Kojima Y; Honjo T; Yamamoto Y; Yamamoto H; Ishibashi S; Hirata K; Hayashi Y
Cardiovasc Res; 2009 May; 82(2):371-81. PubMed ID: 19176597
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide-donating statins: a new concept to boost the lipid-independent effects.
Schirmer SH; Werner CM; Laufs U; Böhm M
Cardiovasc Res; 2012 Jun; 94(3):395-7. PubMed ID: 22499774
[No Abstract] [Full Text] [Related]
20. Effects of atorvastatin on expression of ICAM-1 in atherosclerotic rabbits.
Du B; Xu G; Cao H; Cui W; Lin S; Liu Y; Qin L
J Cardiovasc Med (Hagerstown); 2013 Feb; 14(2):120-6. PubMed ID: 22609871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
